WHO ICTRP trial
The effectiveness, safety and health economic evaluation of progestogen…
ChiCTR2300074428 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300074428 |
|---|---|
| Public title | The effectiveness, safety and health economic evaluation of progestogen treatment for endometrial hyperplasia without atypia: a prospective randomized controlled trial |
| Scientific title | The effectiveness, safety and health economic evaluation of progestogen treatment for endometrial hyperplasia without atypia: a prospective randomized controlled trial |
| Primary sponsor | Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Endometrial hyperplasia (EH) |
| Interventions | Experimental group of therapeutic intervention:Levonorgestrel-releasing intrauterine system;Controlled group of therapeutic intervention:Dydrogesterone;Experimental group of preventive intervention:Levonorgestrel-releasing intrauterine… |
| Registration date | Aug 7, 2023 |
| Target size | Experimental group of therapeutic intervention:136;Controlled group of… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: